Research Site Profile

Research Site Introduction:

At Bioluminux Clinical Research New Jersey, we are committed to advancing medical science while ensuring equitable access to innovative treatments. Located in New Jersey, our state-of-the-art research facility conducts high-quality clinical trials across a broad spectrum of therapeutic areas. Our mission is to improve healthcare outcomes by providing patients with access to cutting-edge treatments while supporting sponsors in delivering rigorous, compliant, and efficient research studies.

Our experienced team, led by a highly skilled principal investigator, upholds the highest ethical and regulatory standards in every study. We prioritize patient safety, comfort, and education, ensuring that every participant is well-informed and supported throughout their clinical trial journey. By fostering a patient-centric approach, we strive to make clinical research more accessible and inclusive for diverse communities.

Collaboration is at the core of our approach. We actively engage with local healthcare providers and community organizations to promote awareness and participation in clinical research, particularly among underrepresented populations. Through these efforts, we aim to bridge healthcare disparities and contribute to medical advancements that benefit all patients.

At Bioluminux Clinical Research New Jersey, we believe in the power of research to transform lives and we welcome the opportunity to work together in shaping the future of medicine.

Research Site Description:

Patient Demographics:

Bioluminux Clinical Research New Jersey serves a diverse and growing patient population, reflecting the socioeconomic and cultural composition of the region. Our strategic location allows us to engage patients from various racial, ethnic, and age groups, ensuring broad representation in clinical research. The patient population spans all age groups, with a predominant representation of adults aged 18-65. Additionally, a significant proportion of residents are over 65, making our site well-suited for studies targeting aging-related conditions such as cardiovascular disease, arthritis, and neurodegenerative disorders. Pediatric studies may also be considered based on trial requirements and regional healthcare needs. 

The Population also boast of a multicultural community, including Caucasian, African American, Hispanic/Latino, and Asian populations. The diversity in the region provides an opportunity for inclusive research that captures a wide range of genetic and environmental factors affecting health outcomes.

The patient population includes individuals from varied socioeconomic backgrounds, with a mix of insured and uninsured individuals. By collaborating with local healthcare providers, community organizations, and advocacy groups, we actively work to reduce barriers to clinical trial participation, ensuring equitable access to innovative treatments.

By understanding and addressing the demographics of our community, Bioluminux Clinical Research New Jersey remains committed to conducting inclusive, high-quality clinical trials that contribute to medical advancements and improved patient outcomes.

Additional Information:

Bioluminux Clinical Research New Jersey is committed to excellence in clinical trials, ensuring patient safety, regulatory compliance, and high-quality data collection. Our facility is equipped with advanced diagnostic tools, and all other neccessary medical equipments to achieve a seamless clinical trials study. We prioritize diversity and inclusivity, engaging underrepresented populations through community partnerships. With an experienced research team and streamlined study processes, we provide efficient clinical trial execution while offering patients access to innovative treatments that contribute to medical advancements and improved healthcare outcome.

Contact Information:

Bioluminus Clinical Research New Jersey

2131 NJ -33, Hamilton NJ 08690

United States.

Phone no - +1 (609) 613-6859